Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
As of close of business last night, 89bio Inc’s stock clocked out at $6.55, up 4.47% from its previous closing price of $6.27. In other words, the price has increased by $4.47 from its previous closing price. On the day, 1.13 million shares were traded. ETNB stock price reached its highest trading level at $6.66 during the session, while it also had its lowest trading level at $6.2748.
Ratios:
To gain a deeper understanding of ETNB’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.19 and its Current Ratio is at 13.19. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on March 14, 2025, initiated with a Neutral rating and assigned the stock a target price of $11.
On March 13, 2025, Citigroup started tracking the stock assigning a Buy rating and target price of $25.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 15 ’25 when Le-Nguyen Quoc sold 15,329 shares for $5.95 per share. The transaction valued at 91,208 led to the insider holds 328,323 shares of the business.
QUOC LE-NGUYEN bought 15,329 shares of ETNB for $91,171 on Apr 15 ’25. On Jan 30 ’25, another insider, RA CAPITAL MANAGEMENT, L.P., who serves as the Director of the company, bought 5,714,285 shares for $8.75 each. As a result, the insider paid 49,999,994 and bolstered with 19,554,319 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ETNB now has a Market Capitalization of 956195200 and an Enterprise Value of 553790400.
Stock Price History:
The Beta on a monthly basis for ETNB is 1.50, which has changed by -0.23659676 over the last 52 weeks, in comparison to a change of 0.042615533 over the same period for the S&P500. Over the past 52 weeks, ETNB has reached a high of $11.84, while it has fallen to a 52-week low of $4.16. The 50-Day Moving Average of the stock is -20.16%, while the 200-Day Moving Average is calculated to be -20.92%.
Shares Statistics:
It appears that ETNB traded 2.67M shares on average per day over the past three months and 1851460 shares per day over the past ten days. A total of 145.98M shares are outstanding, with a floating share count of 140.33M. Insiders hold about 3.88% of the company’s shares, while institutions hold 89.89% stake in the company. Shares short for ETNB as of 1743379200 were 15225634 with a Short Ratio of 5.71, compared to 1740700800 on 9651177. Therefore, it implies a Short% of Shares Outstanding of 15225634 and a Short% of Float of 12.44.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The stock of 89bio Inc (ETNB) is currently being evaluated by 7.0 analysts who are actively contributing to its market rating.The consensus estimate for the next quarter is -$0.48, with high estimates of -$0.4 and low estimates of -$0.56.
Analysts are recommending an EPS of between -$1.83 and -$2.45 for the fiscal current year, implying an average EPS of -$2.06. EPS for the following year is -$2.05, with 8.0 analysts recommending between -$1.36 and -$2.5.
